Charles-Briac Levaché

609 total citations
5 papers, 44 citations indexed

About

Charles-Briac Levaché is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Charles-Briac Levaché has authored 5 papers receiving a total of 44 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in Charles-Briac Levaché's work include Colorectal Cancer Treatments and Studies (2 papers), Cancer Treatment and Pharmacology (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Charles-Briac Levaché is often cited by papers focused on Colorectal Cancer Treatments and Studies (2 papers), Cancer Treatment and Pharmacology (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Charles-Briac Levaché collaborates with scholars based in France, Australia and Belgium. Charles-Briac Levaché's co-authors include Sophie Coutant, Roberto Sorio, Frédéric Di Fiore, Flora Zagouri, Chee Khoon Lee, Ludivine Beaussire, Karine Le Malicot, Philippe Deguiral, Claire Mulot and Gunnar B. Kristensen and has published in prestigious journals such as Journal of Clinical Oncology, Gynecologic Oncology and Modern Pathology.

In The Last Decade

Charles-Briac Levaché

5 papers receiving 44 citations

Peers

Charles-Briac Levaché

ONCOL

RM

SURGE

PRM

PFM

Jean Siedel United States

MJ Battista Germany

F.A.A. Valster Netherlands

Pilar Barretina-Ginesta Spain

Jennifer M. Koziak Canada

Jin Suminokura Japan

J. Yu China

Shanshan Yang China

Zachary T. Olah United States

Mohammad A. Zeineddine United States

Jean Siedel United States

Charles-Briac Levaché

34 ×1.1

ONCOL

20 ×1.1

RM

19 ×1.5

SURGE

17 ×1.4

PRM

8 ×0.7

PFM

Citations per year, relative to Charles-Briac Levaché Charles-Briac Levaché (= 1×) peers Jean Siedel

Countries citing papers authored by Charles-Briac Levaché

Since Specialization

Citations

This map shows the geographic impact of Charles-Briac Levaché's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles-Briac Levaché with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles-Briac Levaché more than expected).

Fields of papers citing papers by Charles-Briac Levaché

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles-Briac Levaché. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles-Briac Levaché. The network helps show where Charles-Briac Levaché may publish in the future.

Co-authorship network of co-authors of Charles-Briac Levaché

This figure shows the co-authorship network connecting the top 25 collaborators of Charles-Briac Levaché. A scholar is included among the top collaborators of Charles-Briac Levaché based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles-Briac Levaché. Charles-Briac Levaché is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Jacob, Paul, Côme Lepage, Claire Gallois, et al.. (2025). Deep Learning on Histologic Slides Accurately Predicts Consensus Molecular Subtypes and Spatial Heterogeneity in Colon Cancer. Modern Pathology. 38(11). 100877–100877. 1 indexed citations

2.

Beaussire, Ludivine, Sylvain Manfrédi, Karine Le Malicot, et al.. (2022). Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer. Frontiers in Oncology. 12. 973167–973167. 10 indexed citations

3.

Boige, Valérie, Éric François, Méher Ben Abdelghani, et al.. (2021). Maintenance treatment with cetuximab versus observation in RAS wild-type metastatic colorectal cancer: Results of the randomized phase II PRODIGE 28-time UNICANCER study.. Journal of Clinical Oncology. 39(3_suppl). 15–15. 8 indexed citations

4.

Sorio, Roberto, C. Roemer-Bécuwe, Felix Hilpert, et al.. (2016). Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial. Gynecologic Oncology. 144(1). 65–71. 22 indexed citations

5.

Bachet, Jean‐Baptiste, Olivier Lucidarme, Julien Taı̈eb, et al.. (2016). FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Results of the FFCD 1102 phase II trial.. Journal of Clinical Oncology. 34(15_suppl). 3513–3513. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact